These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Therapeutic implications of dermoscopic findings in acanthosis nigricans: A clinical and histopathological study. Pardeshi SS; Khemani UN; Kamath RR; Kura MM; Jafferany M Dermatol Ther; 2020 Nov; 33(6):e14521. PubMed ID: 33176058 [TBL] [Abstract][Full Text] [Related]
25. The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents. Masquio DC; de Piano A; Campos RM; Sanches PL; Carnier J; Corgosinho FC; Netto BD; Carvalho-Ferreira JP; Oyama LM; Nascimento CM; de Mello MT; Tufik S; Dâmaso AR Br J Nutr; 2015 Jun; 113(12):1920-30. PubMed ID: 25907896 [TBL] [Abstract][Full Text] [Related]
26. Dermatologic manifestations of polycystic ovary syndrome. Lee AT; Zane LT Am J Clin Dermatol; 2007; 8(4):201-19. PubMed ID: 17645376 [TBL] [Abstract][Full Text] [Related]
27. Polycystic ovary syndrome: a dermatologic approach. Moura HH; Costa DL; Bagatin E; Sodré CT; Manela-Azulay M An Bras Dermatol; 2011; 86(1):111-9. PubMed ID: 21437531 [TBL] [Abstract][Full Text] [Related]
28. Acanthosis nigricans associated with insulin resistance : pathophysiology and management. Hermanns-Lê T; Scheen A; Piérard GE Am J Clin Dermatol; 2004; 5(3):199-203. PubMed ID: 15186199 [TBL] [Abstract][Full Text] [Related]
29. [Woman 19-old with hirsutism, obesity and acanthosis nigricans]. Kępczyńska-Nyk A; Muszel M; Radziszewski M; Wocial K Pol Merkur Lekarski; 2016 Sep; 41(243):141-144. PubMed ID: 27755516 [TBL] [Abstract][Full Text] [Related]
32. Acanthosis nigricans, insulin resistance and cutaneous virilism. Barth JH; Ng LL; Wojnarowska F; Dawber RP Br J Dermatol; 1988 May; 118(5):613-9. PubMed ID: 3293647 [TBL] [Abstract][Full Text] [Related]
33. Acne-associated syndromes: models for better understanding of acne pathogenesis. Chen W; Obermayer-Pietsch B; Hong JB; Melnik BC; Yamasaki O; Dessinioti C; Ju Q; Liakou AI; Al-Khuzaei S; Katsambas A; Ring J; Zouboulis CC J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):637-46. PubMed ID: 21198949 [TBL] [Abstract][Full Text] [Related]
34. Polycystic ovary syndrome: a review for dermatologists: Part I. Diagnosis and manifestations. Housman E; Reynolds RV J Am Acad Dermatol; 2014 Nov; 71(5):847.e1-847.e10; quiz 857-8. PubMed ID: 25437977 [TBL] [Abstract][Full Text] [Related]
35. The Association of Various Metabolic Parameters with Multiple Skin Tags. Platsidaki E; Vasalou V; Gerodimou M; Markantoni V; Kouris A; Vryzaki E; Gregoriou S; Rigopoulos D; Kontochristopoulos G J Clin Aesthet Dermatol; 2018 Oct; 11(10):40-43. PubMed ID: 30519379 [No Abstract] [Full Text] [Related]
36. Thiazolidinediones for the therapeutic management of polycystic ovary syndrome : impact on metabolic and reproductive abnormalities. Elkind-Hirsch KE Treat Endocrinol; 2006; 5(3):171-87. PubMed ID: 16677059 [TBL] [Abstract][Full Text] [Related]
37. [Obese children with benign acanthosis nigricans and insulin resistance: analysis of 19 cases]. Fu JF; Liang L; Dong GP; Jiang YJ; Zou CC Zhonghua Er Ke Za Zhi; 2004 Dec; 42(12):917-9. PubMed ID: 15733362 [TBL] [Abstract][Full Text] [Related]